Completed
Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients
NCT00483756
- Conditions
- Kidney Transplantation
- Locations
-
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Palo Alto, California, United States